In the BioHarmony Drug Report Database
Tegafur
Teysuno (tegafur) is a small molecule pharmaceutical. Tegafur was first approved as Teysuno on 2011-03-14. It has been approved in Europe to treat stomach neoplasms. It is known to target dihydropyrimidine dehydrogenase [NADP(+)].
Trade Name
|
Teysuno |
|---|---|
Common Name
|
tegafur |
ChEMBL ID
|
CHEMBL20883 |
Indication
|
stomach neoplasms |
Drug Class
|
Image (chem structure or protein)